Details of the Drug Reposition

General Information of This Drug (ID: DM0ZIT2)

Drug Name
PTX-200   DM0ZIT2
Synonyms Plant-derived antiparkinsonian, Phytrix

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Breast cancer DIS7DPX1 2C60-2C65 Phase 2 [1]
Parkinson disease DISQVHKL 8A00.0 Phase 2 [2]
------------------------------------------------------------------------------------
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Acute myeloid leukaemia DIS0BM1I 2A60 Phase 1 [1]
Ovarian cancer DISZJHAP 2C73 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
2 PTX-200 Phase 1b/2 clinical trial update. Prescient Therapeutics. 26 August 2015.